Instant Case Decision
See if you qualify for Xarelto / Pradaxa Litigation and the right to potentially significant financial recovery.
The Xarelto / Pradaxa Instant Case Evaluator provides lawsuit qualification information and details regarding your situation.
- Did you or a loved one take Xarelto or Pradaxa?
- Did a bleeding event then develop in you or your loved one?
In recent years, new oral anticoagulants such as Xarelto, Eliquis and Pradaxa have taken over a lot of the market formerly owned by warfarin, because of their “convenience.” Marketed as requiring less effort in blood tests and managing food interactions, these new anticoagulants also carry a risk that was not present in warfarin – no antidote to stop uncontrolled bleeding. Many times the ability to reverse the effects of Xarelto, Eliquis or Pradaxa can be a matter of life or death.
According to the Institute of Safe Medicines Practices (ISMP), a watchdog group, anticoagulant drugs are a “high-risk treatment” and cause bleeding in approximately 15% of patients with atrial fibrillation. Many physicians are wary of the new anticoagulants, since there is limited evidence on how to manage bleeding in patients taking them since there is no known reversal of the anticoagulant effect.
New anticoagulants such as Xarelto, Eliquis and Pradaxa have been linked to an increased number of uncontrollable blood injuries because there was no approved antidote for patients who use the medication.
Pradaxa Lawsuit Settlement
In May 2014, nearly 4,000 individuals harmed by uncontrollable bleeding with the drug Pradaxa received $650 million in compensation for their injuries. More Pradaxa Lawsuits are moving forward today for individuals who were harmed prior to the FDA approval of a Praxbind in October 2015, when the FDA
Xarelto is at the center of numerous lawsuits claiming personal injury and wrongful death. Plaintiffs allegedly suffered uncontrollable bleeding which resulted in severe injuries and deaths caused by Xarelto. Xarelto lawsuits accuse the manufactures of failing to adequately warn consumers and doctors of the side effects that can occur with an uncontrollable bleed and hiding important safety information which resulted in over a hundred deaths and over thousands of fatal injuries.
Xarelto Lawsuits are currently moving forward in the Eastern District of Louisinana presided by the Honorable Kurt D. Engelhardt with the first Bellwether trials set to move forward in February 2017.
Xarelto / Pradaxa Injuries & Side Effects
|Gastrointestinal bleeding||Rectal bleeding|
|Hernia Recurrence||Adhesion (Scar-like tissue that sticks tissues together)|
|Heart Attack||Pulmonary Embolism|
|Epidural Hematoma||Brain Hemorrhage|
Anticoagulant Drugs With No Reversal Agent Still On The Market
The risk of bleeding is a problem with all blood thinners, however, with warfarin, doctors can turn to an “antidote” of Vitamin K to stop the bleeding. Xarelto and Eliquis do not currently have an antidote to stop a severe, life-threatning bleed. However, five years after approval, in October 2015, an antidote for Pradaxa, Praxbind, was finally FDA approved.
Should You File a Xarelto / Pradaxa Lawsuit to Protect Your Legal Rights?
Did you use one of these medications?
Did you then develop a bleeding event?
If you answered yes to these two questions you should look into your legal rights. Fill out our Secure Xarelto / Pradaxa Instant Case Evaluation if you believe you may need to protect your legal rights.
View Your Xarelto Drug Case Analysis Now!
Instant, Secure, No cost/No obligation Analysis of Your Xarelto Lawsuit
Latest Xarelto News
- FDA approves Praxbind, the first reversal agent for the anticoagulant Pradaxa. (2015, October 16). Retrieved from http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm467300.htm
- In Re:Pradaxa (Dabigatran Etexilate) Products Liability Litigation, MDL No. 2385, http://www.ilsd.uscourts.gov/mdl/mdl2385.aspx
- In Re:Xarelto Products Liability Litigation, MDL. No. 2592, http://www.laed.uscourts.gov/xarelto